Business

LTIP awards

LTIP awards.

articleHikma Pharmaceuticals PlcApril 3, 20074/company/hikma-pharmaceuticals-plc/news/ltip-awards-2
LTIP awards

About this update from Hikma Pharmaceuticals Plc

[{"type":"text","content":"\n Hikma Pharmaceuticals Plc\n03 April 2007\n\n\n\n\n Hikma Pharmaceuticals PLC - LTIP Awards\n\nLONDON, 3 April 2007: Hikma Pharmaceuticals PLC (LSE: HIK) (DIFX: HIK) announces\nthat the Remuneration Committee has made the following awards under the Hikma\nPharmaceuticals PLC 2005 Long-Term Incentive Plan (the 'LTIP') to Persons\nDischarging Managerial Responsibility ('PDMRs') of the Company.\n\nAwards were made on 2 April 2007 at a price of £3.87 per ordinary share as\nfollows:-\n\nName of PDMR Number of LTIP Shares\n\nBassam Kanaan 30,000\nNabil Rizk 30,000\nTaghreed Al-Shunnar 25,000\nMajda Labadi 25,000\nGabriel Kalisse 25,000\nMike Raya 25,000\n\nThe shares subject to the LTIP awards will only be released to the participants\nin three years time, subject to their continued employment and the satisfaction\nof the comparative Total Shareholder Return ('TSR') performance target.\nParticipants will only receive the full benefit of their share incentives if TSR\nperformance against the Comparator Group is at least at the upper quartile.\n\n - ENDS -\nEnquiries:\n\nHikma Pharmaceuticals PLC\n\nHenry Knowles +44 20 7399 2760\nCompany Secretary\n\nSusan Ringdal +44 20 7399 2760\nInvestor Relations Director\n\nAbout Hikma\n\nHikma Pharmaceuticals PLC is a multinational pharmaceutical group focused on\ndeveloping, manufacturing and marketing a broad range of both branded and\nnon-branded generic and in-licensed pharmaceutical products. Hikma's operations\nare conducted through three businesses: Generic, Branded and Injectable\nPharmaceuticals. Hikma's operations are based principally in the United States,\nthe Middle East and North Africa ('MENA') region and Europe. In 2006, the Group\nhad revenue of $317 million and profit attributable to shareholders of $54.5\nmillion. For news and other information, please visit www.hikma.com.\n\n\n\n This information is provided by RNS\n The company news service from the London Stock Exchange\n \n ","length":2313,"tagName":"div"}]

More updates from Hikma Pharmaceuticals Plc